Your session is about to expire
← Back to Search
Cold Preservation vs. Machine Perfusion for Liver Transplants
Study Summary
This trial will compare the outcomes of transplanting livers that have been kept alive with a machine after being rejected by other transplant centers, to the outcomes of using livers that have been kept cold.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is access to this research open at this moment in time?
"Affirmative. The information hosted on clinicaltrials.gov states that this medical trial, which was initially advertised on December 3rd 2020, is actively enrolling patients. A total of 25 participants are needed from a single site to complete the study."
What outcomes are researchers aiming to achieve through this clinical trial?
"This clinical trial seeks to evaluate the efficacy of liver transplantation over a 6 month period. Primary outcomes include the number of patients with no graft failure at 6 months, while secondary goals measure quality of life scores using an EQ-5D-5L questionnaire and 90 day and 1 year patient/graft survival rates. Additionally, early allograft dysfunction (EAD) and primary non-function (PNF) will be assessed in order to gauge progress towards long term survivability."
What is the current scale of participation for this trial?
"Affirmative. According to the clinicaltrials.gov website, this medical study is actively seeking enrolments with a start date of December 3rd 2020 and an update posted on February 16th 2022. A total of 25 participants are needed for the trial at one site only."
Share this study with friends
Copy Link
Messenger